Dermata Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Dermata Therapeutics Inc.
Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology for patients suffering with acne. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin.
/ 
Frequently asked questions
To buy Dermata Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Dermata Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Dermata Therapeutics Inc. is DRMA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Dermata Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade Dermata Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Dermata Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Dermata Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Dermata Therapeutics Inc..